Oragenics Inc (OGEN) stock
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.21+0.01 (+6.06%)
Close on Nov 17, 2026Market cap $947.51KP/E –Yield –
Oragenics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Oragenics's revenue for the twelve months ending Dec 31, 2023 was $37.65K, down 71.4% year over year. For fiscal 2023 it was $37.65K, down 71.4% from the year before. Over ten years it grew -29.9% a year on average. The highest annual figure on record is $1.44M in fiscal 2011.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $37.65K | -71.4% |
| FY2022 | Dec 31, 2022 | $131.52K | +51.2% |
| FY2021 | Dec 31, 2021 | $86.99K | – |
| FY2017 | Dec 31, 2017 | $0 | – |
| FY2016 | Dec 31, 2016 | $0 | – |
| FY2015 | Dec 31, 2015 | $0 | -100.0% |
| FY2014 | Dec 31, 2014 | $939.93K | -8.9% |
| FY2013 | Dec 31, 2013 | $1.03M | -22.5% |
| FY2012 | Dec 31, 2012 | $1.33M | -7.8% |
| FY2011 | Dec 31, 2011 | $1.44M | +10.4% |
| FY2010 | Dec 31, 2010 | $1.31M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $7.47K | -91.3% |
| Q2 FY2023 | Jun 30, 2023 | $13.16K | -56.7% |
| Q1 FY2023 | Mar 31, 2023 | $17.02K | +12.9% |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022 | Sep 30, 2022 | $86.05K | – |
| Q2 FY2022 | Jun 30, 2022 | $30.39K | – |
| Q1 FY2022 | Mar 31, 2022 | $15.08K | – |
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
| Q3 FY2018 | Sep 30, 2018 | $0 | – |
| Q2 FY2018 | Jun 30, 2018 | $0 | – |
| Q1 FY2018 | Mar 31, 2018 | $0 | – |
| Q4 FY2017 | Dec 31, 2017 | $0 | – |
| Q3 FY2017 | Sep 30, 2017 | $0 | – |
| Q2 FY2017 | Jun 30, 2017 | $0 | – |
| Q1 FY2017 | Mar 31, 2017 | $0 | – |
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
See a number that looks wrong?